Fri.Mar 21, 2025

article thumbnail

Do you have ADHD? That TikTok might not help you decide

NPR - Mental Health

Ever diagnosed yourself with a mental health disorder based on a TikTok video? If so, you're not alone. "I personally don't think that there's anything more human than wanting to understand yourself and wanting to understand your own experiences," says Vasileia Karasavva. Vasileia is the lead author of a paper published Wednesday in the journal PLOS One that gets into why this kind of self-diagnosis can be such a double-edged sword.

190
190
article thumbnail

When Narratives Clash: Unshrunk and The Cognitive Dissonance of the NY Times

Mad in America

O n March 19, Viking Press published Laura Delanos memoir: Unshrunk: A Story of Psychiatric Treatment Resistance. While a number of writers have published memoirs telling of harm that stemmed from a psychiatric diagnosis and treatment with psychiatric drugs, this is a book, precisely because it is being published by a major publisher, that appears certain to gain major media attention, which has been lacking for other memoirs that told of harm.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Difficulties With Insurance and Patient Care: “Why Is the System So Complicated?”

Psychiatric Times

Legislative and legal realities at the state and federal levels are difficult to navigate even for seasoned practitioners, and are beyond the knowledge of most families.

Insurance 105
article thumbnail

Potential risk biomarkers found for schizophrenia resulting from cannabis use

Psychiatry News -- Science Daily

A new study has analyzed and compared the fatty acids in the blood of individuals with schizophrenia, of those with cannabis use disorder and of those with both diagnoses, with the aim of shedding light on new biomarkers and improving the understanding of the biological relationship between the two disorders. The study also offers a powerful tool for identifying new biomarkers.

105
105
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Una expaciente psiquiátrica lidera un movimiento para dejar los fármacos

The New York Times -- Mental Health

Laura Delano se alej de los tratamientos psicotrpicos que definieron parte de su juventud. Ahora espera crear una hoja de ruta que otros puedan seguir. Los profesionales consideran los riesgos.

article thumbnail

Nearly half of depression diagnoses could be considered treatment-resistant

Psychiatry News -- Science Daily

Almost half of patients diagnosed with depression classify as being 'treatment-resistant' as new research suggests that many don't respond to multiple antidepressant options.

90

More Trending

article thumbnail

Kindness Will Make You Happier Than a Higher Salary

Association for Psychological Science (APS)

The world may feel cold, scary and cruel, but if you are open to seeing it, there is a lot of kindness, according to a new report. … Even though the world feels like its a pretty difficult place right now, it is nice to know that people are engaging in kind and generous acts, said Dr. Lara Aknin , professor of social psychology at Simon Fraser University in British Columbia and an editor of the World Happiness Report.

article thumbnail

What Is Intellectual Developmental Disorder?

Child Mind Intitute

When a parent finds out their child might have intellectual developmental disorder also known as intellectual disability, intellectual and developmental disability, or IDD they might have more questions than answers. IDD is a catch-all term for a range of different conditions (including what years ago was called mental retardation, a designation that is no longer used), and families may need to wait to see how children change as they grow.

article thumbnail

Psychiatric Drugs: Getting Off vs. Staying On

The New York Times -- Mental Health

A psychiatrist and a patient respond to an article in Science Times. Also: A plea to Congress; an upside-down definition of waste, fraud and abuse.

article thumbnail

"Leave Nothing Untouched": Pervasive Challenges in the Neuropsychiatric Space

Psychiatric Times

What are the most pressing issues facing psychiatry? Gustavo Alva, MD, FAPA, shares his thoughts.

52
article thumbnail

Intersections of Psychological Research and Psychotherapeutic Practices

History Psychiatry

The Programm of the 10th International Workshop on Historical Epistemology will be of interest to h-madness readers.

45
article thumbnail

Cognition Is Like Art—You Know It When You See It

Psychiatric Times

Review various aspects of cognition in our latest Special Report.

51
article thumbnail

Thinking About Recovery? Here’s What You Need to Know about Addiction Inpatient Treatment  

Clear Behavioral Health

Acknowledging the need for help can feel overwhelming and scary. Having more knowledge on substance use recovery treatment can be what you need to gain the courage to take that first step. Substance use disorders are treatable with the resources that are currently available like inpatient treatment for addiction. You can maintain a successful recovery through a combination of different treatments including therapy, medications, 12-step programs, along with drug and alcohol rehab.

article thumbnail

"Good Bones"

Psychiatric Times

"Any decent realtor, walking you through a real shithole, chirps on about good bones: This place could be beautiful, right? You could make this place beautiful.

40
article thumbnail

Psychiatric Organizations Respond to Federal Concerns Over Psychotropic Medications, SAMHSA Budget Cuts

Psychiatric Times

Joint statements from leading psychiatric organizations voice concern about impact on patient care from executive orders and budget cuts.

110
110
article thumbnail

John J. Miller, MD, Responds to Statement on Psychotropic Medication Concerns

Psychiatric Times

Psychiatric Times Editor in Chief John J. Miller, MD, shares thoughts on psychiatry's response to the recent executive order.

52